These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15102544)

  • 41. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of genetic mechanisms on plasma lipoprotein metabolism and the pathogenesis of atherosclerosis.
    Kwiterovich PO; Bachorik PS; Chatterjee S
    Prog Clin Biol Res; 1979; 32():65-112. PubMed ID: 230521
    [No Abstract]   [Full Text] [Related]  

  • 43. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.
    Agouridis AP; Filippatos TD; Tsimihodimos V; Elisaf MS
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):355-66. PubMed ID: 21438815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Physiological effects of modified LDL on vascular smooth muscle cells in hyperlipidemia].
    Takahashi K; Saito Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():572-7. PubMed ID: 11347134
    [No Abstract]   [Full Text] [Related]  

  • 46. [Probucol].
    Yagyu H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():631-6. PubMed ID: 11347145
    [No Abstract]   [Full Text] [Related]  

  • 47. Stimulatory effect of allantoin on imidazoline I₁ receptors in animal and cell line.
    Yang TT; Chiu NH; Chung HH; Hsu CT; Lee WJ; Cheng JT
    Horm Metab Res; 2012 Nov; 44(12):879-84. PubMed ID: 22588708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diabetes mellitus and hyperlipidemia].
    Uchida N; Shuto Y; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():733-7. PubMed ID: 11347163
    [No Abstract]   [Full Text] [Related]  

  • 49. Lipemia Retinalis in a Baby with Hyperlipoproteinemia.
    Maytal A; Ela-Dalman N
    Ophthalmology; 2022 Mar; 129(3):321. PubMed ID: 35190097
    [No Abstract]   [Full Text] [Related]  

  • 50. When and how to treat hyperlipidemia.
    Kuo PT
    Prim Care; 1985 Mar; 12(1):77-89. PubMed ID: 3873080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
    Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
    Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lomitapide.
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):347-52. PubMed ID: 21846156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic considerations for postprandial dyslipidaemia.
    Burnett JR; Watts GF
    Diabetes Obes Metab; 2001 Jun; 3(3):143-56. PubMed ID: 11412278
    [No Abstract]   [Full Text] [Related]  

  • 54. Lipid disorders. Summary and table.
    Coleman SG; Brooke G
    Drugs R D; 1999 Jun; 1(6):471-5. PubMed ID: 10566086
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary hyperlipidaemia.
    Thompson GR
    Br Med Bull; 1990 Oct; 46(4):986-1004. PubMed ID: 2100694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hyperlipidemia in life style disease].
    Oikawa S
    J Nippon Med Sch; 2001 Apr; 68(2):194-7. PubMed ID: 11301367
    [No Abstract]   [Full Text] [Related]  

  • 57. New studies in atherosclerosis research.
    Stock J
    Atherosclerosis; 2011 Dec; 219(2):399-401. PubMed ID: 22078130
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of disorders of cholesterol, triglyceride, and lipoprotein metabolism. Report 6 of the Council on Scientific Affairs.
    Arch Fam Med; 1995 Oct; 4(10):869-78. PubMed ID: 7551135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cincinnati Lipid Research Clinic: review of genetic data and design, limitations and prospects.
    Chung CS
    Prog Clin Biol Res; 1984; 147():135-47. PubMed ID: 6610875
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effectiveness and tolerance of Sedalipid in the treatment of hyperlipoproteinemias].
    Brusis OA; Schmidt A; Upmeyer HJ
    Fortschr Med; 1985 Nov; 103(43):1011-4. PubMed ID: 3912311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.